Partner with us

Pharmaceutical companies, investors and policymakers each play a unique and critical role in the global health ecosystem, and collectively, determine the availability of essential healthcare products worldwide. 

At the Access to Medicine Foundation, we know what is possible when diverse actors unite around a shared goal. By working directly with these actors to provide guidance and facilitate partnerships, we help stakeholders address the barriers that prevent essential healthcare products from reaching those who need them most. 

We engage with companies, governments, investors and global health organisations to advance access to essential medicines for people living in low-and middle-income countries. Through targeted meetings, briefings and workshops, we share the Foundation’s research insights and work with large, research-based pharmaceutical companies, generic medicine manufacturers and small- and medium-sized enterprises to explore opportunities and strengthen the best practices. In parallel, we support government representatives – as well as private foundations, multilateral organisations, and NGOs in shaping policy environment that accelerates innovation, ensures equitable pricing, supports local production, guides resource allocation and strengthens pandemic preparedness. We also work with institutional investors to use our analyses to identify risks and opportunities, guide engagement with portfolio companies, and support more responsible investment decisions.